论文部分内容阅读
Personalized Cancer medicine is a much used term to describe molecular cancer medicine (MCM).In MCM the fruits of molecular biology have resulted in the identification of targets that differ qualitatively and/or quantitatively from normal cells, thus creating a therapeutic window for targeted drugs.We have druggable and nondruggable targets.MCM wants to provide the right drug to the right patient at the right time and at the right dose.MCM will profoundly impact prevention, diagnostics and care alike.